OTC Pharmaceuticals in Australia

OTC Pharmaceuticals in Australia industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2011-15, and forecast to 2020). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Scope

Essential resource for top-line data and analysis covering the Australia otc pharmaceuticals market. Includes market size and segmentation data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Reasons to buy

_x005F What was the size of the Australia otc pharmaceuticals market by value in 2015

_x005F What will be the size of the Australia otc pharmaceuticals market in 2020

_x005F What factors are affecting the strength of competition in the Australia otc pharmaceuticals market

_x005F How has the market performed over the last five years

_x005F Who are the top competitors in Australia's otc pharmaceuticals market

Companies mentioned

GlaxoSmithKline Plc

Pfizer Inc.

Reckitt Benckiser Group plc

Suntory Group

Table of Contents

Executive Summary

Market value

Market value forecast

Category segmentation

Geography segmentation

Market share

Market rivalry

Market Overview

Market definition

Market analysis

Market Data

Market value

Market Segmentation

Category segmentation

Geography segmentation

Market share

Market distribution

Market Outlook

Market value forecast

Five Forces Analysis

Summary

Buyer power

Supplier power

New entrants

Threat of substitutes

Degree of rivalry

Leading Companies

GlaxoSmithKline Plc

Pfizer Inc.

Reckitt Benckiser Group plc

Suntory Group

Macroeconomic Indicators

Country data

Methodology

Industry associations

Related MarketLine research

Appendix

About MarketLine

List of Tables

Table 1: Australia OTC pharmaceuticals market value: $ million, 201115

Table 2: Australia OTC pharmaceuticals market category segmentation: $ million, 2015

Table 3: Australia OTC pharmaceuticals market geography segmentation: $ million, 2015

Table 4: Australia OTC pharmaceuticals market share: % share, by value, 2015

Table 5: Australia OTC pharmaceuticals market distribution: % share, by value, 2015

Table 6: Australia OTC pharmaceuticals market value forecast: $ million, 201520

Table 7: GlaxoSmithKline Plc: key facts

Table 8: GlaxoSmithKline Plc: key financials ($)

Table 9: GlaxoSmithKline Plc: key financials (£)

Table 10: GlaxoSmithKline Plc: key financial ratios

Table 11: Pfizer Inc.: key facts

Table 12: Pfizer Inc.: key financials ($)

Table 13: Pfizer Inc.: key financial ratios

Table 14: Reckitt Benckiser Group plc: key facts

Table 15: Reckitt Benckiser Group plc: key financials ($)

Table 16: Reckitt Benckiser Group plc: key financials (£)

Table 17: Reckitt Benckiser Group plc: key financial ratios

Table 18: Suntory Group: key facts

Table 19: Suntory Group: key financials ($)

Table 20: Suntory Group: key financials (Â¥)

Table 21: Suntory Group: key financial ratios

Table 22: Australia size of population (million), 201115

Table 23: Australia gdp (constant 2005 prices, $ billion), 201115

Table 24: Australia gdp (current prices, $ billion), 201115

Table 25: Australia inflation, 201115

Table 26: Australia consumer price index (absolute), 201115

Table 27: Australia exchange rate, 201115

List of Figures

Figure 1: Australia OTC pharmaceuticals market value: $ million, 201115

Figure 2: Australia OTC pharmaceuticals market category segmentation: % share, by value, 2015

Figure 3: Australia OTC pharmaceuticals market geography segmentation: % share, by value, 2015

Figure 4: Australia OTC pharmaceuticals market share: % share, by value, 2015

Figure 5: Australia OTC pharmaceuticals market distribution: % share, by value, 2015

Figure 6: Australia OTC pharmaceuticals market value forecast: $ million, 201520

Figure 7: Forces driving competition in the OTC pharmaceuticals market in Australia, 2015

Figure 8: Drivers of buyer power in the OTC pharmaceuticals market in Australia, 2015

Figure 9: Drivers of supplier power in the OTC pharmaceuticals market in Australia, 2015

Figure 10: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in Australia, 2015

Figure 11: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in Australia, 2015

Figure 12: Drivers of degree of rivalry in the OTC pharmaceuticals market in Australia, 2015

Figure 13: GlaxoSmithKline Plc: revenues & profitability

Figure 14: GlaxoSmithKline Plc: assets & liabilities

Figure 15: Pfizer Inc.: revenues & profitability

Figure 16: Pfizer Inc.: assets & liabilities

Figure 17: Reckitt Benckiser Group plc: revenues & profitability

Figure 18: Reckitt Benckiser Group plc: assets & liabilities

Figure 19: Suntory Group: revenues & profitability

Figure 20: Suntory Group: assets & liabilities

    Pricing

Discounts available for multiple report purchases.

reportstore@marketline.com
+44 (0) 161 359 5817

Saved reports